23 July 2008 21:57 [Source: ICIS news]
Net sales were $1.12bn, up from $915m reported for the first quarter of 2007.
Airgas attributed much of the growth to products sold to markets in healthcare, life sciences, research, environmental and food and beverages. Those markets make up 40% of the company's sales, and they grew by 10%, said CEO Peter McCausland.
Acquisitions also boosted growth, and the company has announced more than $130m of acquired annual revenue since April, McCausland said.
Total costs and expenses were $982m, up from $804m for the same time last year, Airgas said.
Airgas increased its full-year earnings expectations to $3.30-$3.40/share, up from an earlier target of $3.24-$3.40/share.
Airgas shares traded at $59.33 on the New York Stock Exchange, down 0.64%.
($1 = €0.63)To discuss issues facing the chemical industry go to ICIS connect
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|